Intelligent Bio Solutions Files 8-K
Ticker: INBS · Form: 8-K · Filed: Nov 13, 2024 · CIK: 1725430
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
IBSI filed an 8-K, but no juicy details yet.
AI Summary
Intelligent Bio Solutions Inc. filed an 8-K on November 13, 2024, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific financial figures or details about the "Other Events" at this time.
Why It Matters
This 8-K filing indicates that Intelligent Bio Solutions Inc. has made a regulatory submission to the SEC, which may contain important updates about the company's operations or financial status.
Risk Assessment
Risk Level: low — The filing is a standard procedural report and does not contain information that inherently increases risk.
Key Players & Entities
- Intelligent Bio Solutions Inc. (company) — Registrant
- November 13, 2024 (date) — Date of Report
- 135 West 41st Street, 5th Floor New York, NY 10036 (address) — Principal executive offices
FAQ
What specific 'Other Events' are being reported by Intelligent Bio Solutions Inc. in this 8-K filing?
The provided text of the 8-K filing does not specify the details of the 'Other Events' being reported.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted on November 13, 2024.
What is the principal executive office address for Intelligent Bio Solutions Inc.?
The principal executive office address is 135 West 41st Street, 5th Floor, New York, NY 10036.
What is the SEC file number for Intelligent Bio Solutions Inc.?
The SEC file number for Intelligent Bio Solutions Inc. is 001-39825.
Does this filing include specific financial statements or exhibits?
The filing is categorized as including 'Financial Statements and Exhibits', but the specific content of these exhibits is not detailed in the provided text.
Filing Stats: 443 words · 2 min read · ~1 pages · Grade level 11.1 · Accepted 2024-11-13 17:15:21
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value INBS The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 36KB
- ex99-1.htm (EX-99.1) — 17KB
- ex99-1_001.jpg (GRAPHIC) — 111KB
- 0001493152-24-045197.txt ( ) — 383KB
- inbs-20241113.xsd (EX-101.SCH) — 3KB
- inbs-20241113_lab.xml (EX-101.LAB) — 33KB
- inbs-20241113_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 13, 2024 INTELLIGENT BIO SOLUTIONS INC. By: /s/ Spiro Sakiris Name: Spiro Sakiris Title: Chief Financial Officer